Former Harvard scientist Li Bo was sentenced on charges of making false statements and subsequently rebuilt his brain-computer interface laboratory in Shenzhen.

China News Today report

Former Harvard Scientist Convicted, Rebuilds Brain-Computer Lab in China

Published / April 30, 2026, 19:59

Charles Lieber, the former Harvard scientist convicted of making false statements to U.S. federal investigators over payment issues in China, has now rebuilt his research laboratory in Shenzhen.

Lieber’s new lab, i-BRAIN, is dedicated to developing brain-computer interface (BCI) technologies, which are designated as a national priority by the Chinese government and hold significant potential in both medical and military applications.

This news about former Harvard scientist Charles Lieber reestablishing his lab in Shenzhen marks a new variable emerging in the global competition for brain-computer interfaces. This is not only a personal “rebirth” for Lieber but also reflects the complex shift between the U.S. and China—from decoupling to building parallel systems in cutting-edge scientific fields.

This incident once again demonstrates that despite U.S. attempts to restrict collaboration between scientists and China through legal and administrative measures, the mobility of technology and the profit-driven nature of capital are difficult to fully contain.

Lieber’s case illustrates that when the domestic political and legal environment in the United States becomes “unfriendly” toward certain scientists, China—with its vast market potential and strong policy support—has become an ideal “safe haven” and “laboratory” for such researchers.

The lure of practical applications: China’s massive demand in medical rehabilitation (e.g., for paralyzed or ALS patients), combined with relatively efficient clinical trial approval processes (such as the upcoming BCI future industry cluster zone being developed in Shanghai), presents a fatal attraction for scientists urgently seeking to validate their technologies.

Lieber’s establishment of a new lab in Shenzhen is the outcome of the collision between “U.S. legal sanctions” and “China’s industrial demand.”

For China, attracting top-tier talents like Lieber helps bridge gaps in the “future industry” of brain-computer interfaces, particularly in micro-nano electronics and flexible materials. For Lieber himself, this represents the best path to overcome legal setbacks and achieve technological commercialization. It also signals that in the exploration of neuroscience—the ultimate frontier—China is becoming an indispensable stage for global scientists.

Original source: toutiao.com/article/1863952863661132/

Disclaimer: The views expressed in this article are solely those of the author.